About Lunaphore Technologies SA
Lunaphore Technologies SA: Revolutionizing Spatial Biology Research
Lunaphore Technologies SA is a Swiss-based spatial biology company that specializes in developing multiplex immunofluorescence and IHC solutions for discovery and immuno-oncology research. The company was founded in 2014 by Ata Tuna Ciftlik, Kevin Alessandri, and Diego Dupouy with the aim of revolutionizing the field of spatial biology research.
Spatial biology is an emerging field that focuses on understanding the three-dimensional organization of cells and tissues within biological systems. This approach allows researchers to gain a deeper understanding of how cells interact with each other and their environment, which can provide valuable insights into disease mechanisms and potential therapeutic targets.
Lunaphore's innovative technology platform enables researchers to perform high-throughput analysis of tissue samples with unprecedented speed, accuracy, and sensitivity. Their proprietary microfluidic technology allows for rapid staining of multiple biomarkers on a single slide, enabling researchers to obtain more comprehensive data from each sample.
The company's flagship product is the LabSat® Research instrument, which combines Lunaphore's microfluidic technology with advanced imaging capabilities to provide highly detailed spatial information about tissue samples. The LabSat® Research system can analyze up to six biomarkers simultaneously on a single slide in just one hour, making it an ideal tool for high-throughput screening applications.
In addition to its LabSat® Research system, Lunaphore also offers a range of consumables such as reagents and antibodies that are optimized for use with their microfluidic technology platform. These products are designed to ensure consistent results across different experiments while minimizing variability between samples.
One area where Lunaphore's technology has shown particular promise is in immuno-oncology research. Immuno-oncology is an exciting new field that focuses on harnessing the power of the immune system to fight cancer. By analyzing tumor samples at a cellular level using Lunaphore's technology platform, researchers can gain insights into how different immune cells interact with cancer cells within tumors.
This information can be used to develop new immunotherapies that target specific immune cell populations or pathways involved in tumor growth or metastasis. In addition, Lunaphore's technology could also be used as a diagnostic tool for identifying patients who are most likely to respond positively to immunotherapy treatments based on their individual tumor characteristics.
Overall, Lunaphore Technologies SA represents an exciting new player in the field of spatial biology research. With its innovative microfluidic technology platform and focus on developing solutions for immuno-oncology research applications, this Swiss-based company has positioned itself as a leader in this rapidly evolving field.